D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson's Disease
Neurol Neurochir Pol
.
2021;55(6):595-597.
doi: 10.5603/PJNNS.a2021.0080.
Epub 2021 Oct 27.
Authors
Agnieszka Jadwiga Antos
1
,
Tomasz Litwin
2
,
Adam Przybyłkowski
3
,
Marta Skowrońska
2
,
Iwona Kurkowska-Jastrzębska
2
,
Anna Członkowska
2
Affiliations
1
Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland. agnieszkaantos91@wp.pl.
2
Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
3
Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
PMID:
34704604
DOI:
10.5603/PJNNS.a2021.0080
No abstract available
Publication types
Case Reports
MeSH terms
Adult
Hepatolenticular Degeneration* / drug therapy
Humans
Lupus Erythematosus, Systemic* / chemically induced
Lupus Erythematosus, Systemic* / drug therapy
Male
Penicillamine* / adverse effects
Substances
Penicillamine